The VA Research Enterprise: A Platform for National Partnerships Toward Evidence Building and Scientific Innovation

Amanda P Garcia; Grant D Huang; Louise Arnheim; Rachel B Ramoni; Carolyn M Clancy

doi:10.12788/fp.0425

The VA Research Enterprise: A Platform for National Partnerships Toward Evidence Building and Scientific Innovation

Fed Pract. 2023 Nov;40(11 Suppl 5):S12-S17. doi: 10.12788/fp.0425. Epub 2023 Nov 1.

Authors

Amanda P Garcia¹, Grant D Huang¹, Louise Arnheim², Rachel B Ramoni¹, Carolyn M Clancy²

Affiliations

¹ Office of Research and Development, Department of Veterans Affairs, Washington, DC.
² Office of Discovery, Education and Affiliate Networks, Department of Veterans Affairs, Washington, DC.

Abstract

Background: Within a year of the start of the COVID-19 pandemic, the US Department of Veterans Affairs (VA) was managing about 300 COVID-19-related research projects across roughly 100 facilities, which has since grown to more than 900 projects. This robust set of activities arose from an existing enterprise strategy and aimed at identifying needs for supporting the clinical care mission, more rapidly leveraging resources, and coordinating research across the VA. The VA's efforts to implement an enterprise strategy before March 2020 positioned its research community to dynamically partner with other federal agencies, academic institutions, and industry in addressing a national public health emergency.

Observations: The VA research enterprise involves a broad range of functions, scientific and clinical leaders, and organizational resources to enhance the health and care of veterans and the nation. The scope of research activities enables it to support its priorities while also partnering with others who share in mutual commitments to veteran health. Moving toward being the nation's learning health care system, the VA's leadership support, staff, patient volunteers, and partners were key contributors to a national response to COVID-19. Swift action and consistent communication helped address the complexities of the pandemic and strengthened the VA's ability to prepare and mobilize for emergencies and other potential disease outbreaks. Documenting strategies and practices can enhance future opportunities aimed at addressing the most challenging health care needs while also focusing on the primary mission to serve veterans.

Conclusions: The COVID-19 pandemic contributed to critical knowledge and lessons that enabled the VA to advance enterprise goals, particularly in the context of its health care system. Sharing these unique processes and experiences will inform current and future partnerships among research, clinical, and public health communities oriented to serve veterans and the nation through scientific innovation.